Trial intelligence / Profile preview

Effect of Pioglitazone on 24-hour Blood Pressure

2005-000570-52Phase 4Completed

Sponsor
Cognitive Research Corporation
Start
Oct 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in essential hypertension comparing Pioglitazone (Actos) arm with Placebo arm (2 arms). Primary endpoint: Mean 24-hour systolic blood pressure. Started Oct 2005; status: completed.

02

Drugs

pioglitazone
03

Conditions

essential hypertension

Beyond the preview

Go deeper on 2005-000570-52.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000570-52.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call